BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1400060)

  • 1. Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble.
    Enhorning G; Shumel B; Keicher L; Sokolowski J; Holm BA
    J Appl Physiol (1985); 1992 Sep; 73(3):941-5. PubMed ID: 1400060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pulmonary surfactant function by phospholipases.
    Holm BA; Keicher L; Liu MY; Sokolowski J; Enhorning G
    J Appl Physiol (1985); 1991 Jul; 71(1):317-21. PubMed ID: 1917756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.
    Hite RD; Seeds MC; Jacinto RB; Balasubramanian R; Waite M; Bass D
    Am J Physiol; 1998 Oct; 275(4):L740-7. PubMed ID: 9755106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deacylation of dipalmitoyllecithin by phospholipases A in alveolar macrophages.
    Rao RH; Waite M; Myrvik QN
    Exp Lung Res; 1981 Mar; 2(1):9-15. PubMed ID: 7049685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
    Wang Z; Schwan AL; Lairson LL; O'Donnell JS; Byrne GF; Foye A; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A secreted by Legionella pneumophila destroys alveolar surfactant phospholipids.
    Flieger A; Gongab S; Faigle M; Mayer HA; Kehrer U; Mussotter J; Bartmann P; Neumeister B
    FEMS Microbiol Lett; 2000 Jul; 188(2):129-33. PubMed ID: 10913695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins.
    Cockshutt AM; Possmayer F
    Biochim Biophys Acta; 1991 Oct; 1086(1):63-71. PubMed ID: 1954245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.
    Walther FJ; Waring AJ; Hernandez-Juviel JM; Gordon LM; Schwan AL; Jung CL; Chang Y; Wang Z; Notter RH
    PLoS One; 2007 Oct; 2(10):e1039. PubMed ID: 17940603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube.
    Enhorning G; Holm BA
    J Appl Physiol (1985); 1993 Jun; 74(6):2922-7. PubMed ID: 8365993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraalveolar bubbles and bubble films: II. Formation in vivo through adulthood.
    Scarpelli EM; Mautone AJ; DeFouw DO; Clutario BC
    Anat Rec; 1996 Oct; 246(2):245-70. PubMed ID: 8888967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface activity in situ, in vivo, and in the captive bubble surfactometer.
    Schürch S; Bachofen H; Possmayer F
    Comp Biochem Physiol A Mol Integr Physiol; 2001 May; 129(1):195-207. PubMed ID: 11369544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface properties after a simulated PLA2 hydrolysis of pulmonary surfactant's main component, DPPC.
    Lema G; Enhorning G
    Biochim Biophys Acta; 1997 Mar; 1345(1):86-92. PubMed ID: 9084505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome.
    Touqui L; Wu YZ
    Acta Pharmacol Sin; 2003 Dec; 24(12):1292-6. PubMed ID: 14653960
    [No Abstract]   [Full Text] [Related]  

  • 17. A spreading technique for forming film in a captive bubble.
    Putz G; Walch M; Van Eijk M; Haagsman HP
    Biophys J; 1998 Nov; 75(5):2229-39. PubMed ID: 9788918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study.
    Schrama AJ; de Beaufort AJ; Sukul YR; Jansen SM; Poorthuis BJ; Berger HM
    Acta Paediatr; 2001 Apr; 90(4):412-6. PubMed ID: 11332933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
    J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophospholipid and fatty acid inhibition of pulmonary surfactant: non-enzymatic models of phospholipase A2 surfactant hydrolysis.
    Hite RD; Seeds MC; Jacinto RB; Grier BL; Waite BM; Bass DA
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):14-21. PubMed ID: 16376294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.